Literature DB >> 10328516

Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism.

Y Clouâtre, M Leblanc, D Ouimet, V Pichette.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328516     DOI: 10.1093/ndt/14.4.1047

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  12 in total

1.  Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis.

Authors:  Tansu Sav; Aydin Unal; Abdulsamet Erden; Ali Ihsan Gunal
Journal:  Int Urol Nephrol       Date:  2011-05-07       Impact factor: 2.370

2.  Rhabdomyolysis-induced acute renal failure following fenofibrate therapy: a case report and literature review.

Authors:  Ramazan Danis; Sami Akbulut; Sehmus Ozmen; Senay Arikan
Journal:  Case Rep Med       Date:  2010-07-25

Review 3.  A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.

Authors:  Venkata M Alla; Vrinda Agrawal; Andrew DeNazareth; Syed Mohiuddin; Sudha Ravilla; Marc Rendell
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

4.  Rhabdomyolysis: a case study exploring the possible side effect of lipid lowering medication by a HIV positive patient taking a protease inhibitor.

Authors:  Diana De Carvalho; Mark Citro; Anthony Tibbles
Journal:  J Can Chiropr Assoc       Date:  2008-12

Review 5.  Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.

Authors:  Gillian M Keating; Douglas Ormrod
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics.

Authors:  Aiming Liu; Andrew D Patterson; Zongtao Yang; Xinying Zhang; Wei Liu; Fayang Qiu; He Sun; Kristopher W Krausz; Jeffrey R Idle; Frank J Gonzalez; Renke Dai
Journal:  Drug Metab Dispos       Date:  2009-02-27       Impact factor: 3.922

Review 7.  Fibrates in combination with statins in the management of dyslipidemia.

Authors:  Terry A Jacobson; Franklin H Zimmerman
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

8.  A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report.

Authors:  Muharrem Kiskac; Mehmet Zorlu; Mustafa Cakirca; Cumali Karatoprak; Celalettin Peru; Reha Erkoc; Erdinc Yavuz
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

Review 9.  Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy.

Authors:  Nicola Tarantino; Francesco Santoro; Luisa De Gennaro; Michele Correale; Francesca Guastafierro; Antonio Gaglione; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Vasc Health Risk Manag       Date:  2017-02-16

Review 10.  Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.

Authors:  Jianyong Wu; Yan Song; Heng Li; Jianghua Chen
Journal:  Eur J Clin Pharmacol       Date:  2009-09-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.